Ligand profile
ZINC14982711
Virtual-screening candidate from ZINC.
Bound to: KP13_04425 — Aryl-phospho-beta-D-glucosidase bglC
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC14982711- UniProt (similar protein)
P12614- Tanimoto
- 0.514
- Target protein
- KP13_04425
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 86.7
- −1 ≤ LogP ≤ 5 4.78
- MW ≤ 500 Da 434.6
- LogP ≤ 5 4.78
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 14
- TPSA ≤ 140 Ų 86.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CN(C)c1cccc2c(S(=O)(=O)NCCCCCCCCCCC(=O)O)cccc12CN(C)c1cccc2c(S(=O)(=O)NCCCCCCCCCCC(=O)O)cccc12
InChI=1S/C23H34N2O4S/c1-25(2)21-15-11-14-20-19(21)13-12-16-22(20)30(28,29)24-18-10-8-6-4-3-5-7-9-17-23(26)27/h11-16,24H,3-10,17-18H2,1-2H3,(H,26,27)InChI=1S/C23H34N2O4S/c1-25(2)21-15-11-14-20-19(21)13-12-16-22(20)30(28,29)24-18-10-8-6-4-3-5-7-9-17-23(26)27/h11-16,24H,3-10,17-18H2,1-2H3,(H,26,27)
CEPGVMDMVJGHFQ-UHFFFAOYSA-NCEPGVMDMVJGHFQ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL402127
- Homolog
- P12614
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC14982711 →
- ZINC ZINC20 ZINC14982711 →
- UniProt UniProt P12614 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC14982711”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04425.
PDB 6
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 4
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).